908 Devices Inc.
MASS7.380USD
-0.420-5.38%
Fechamento 11/07, 16:00（ET）Cotações atrasadas em 15 min
266.10MValor de mercado
PerdaP/L TTM
Mais detalhes de 908 Devices Inc. Empresa
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Informações de 908 Devices Inc.
Código da empresaMASS
Nome da Empresa908 Devices Inc
Data de listagemDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Número de funcionários246
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 18
Endereço645 Summer Street
CidadeBOSTON
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal02210
Telefone19787294478
Sitehttps://908devices.com/
Código da empresaMASS
Data de listagemDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Executivos da empresa 908 Devices Inc.
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Dr. Brandi C. Vann, Ph.D.
Dr. Brandi C. Vann, Ph.D.
Independent Director
Independent Director
--
--
Jon Frattaroli
Jon Frattaroli
Vice President - Strategy
Vice President - Strategy
--
--
Mr. E. Kevin Hrusovsky
Mr. E. Kevin Hrusovsky
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Barbara Russo
Ms. Barbara Russo
Vice President - Marketing and Corporate Communications
Vice President - Marketing and Corporate Communications
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kevin J. Knopp, Ph.D.
Dr. Kevin J. Knopp, Ph.D.
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.26M
+2.43%
Dr. Christopher D. Brown, Ph.D.
Dr. Christopher D. Brown, Ph.D.
Co-Founder, Director
Co-Founder, Director
962.12K
--
Mr. Mark Spoto
Mr. Mark Spoto
Independent Director
Independent Director
74.33K
+18.05%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
26.81K
+73.55%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
25.29K
+81.60%
Ms. Michele M. Leonhart
Ms. Michele M. Leonhart
Independent Director
Independent Director
6.49K
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
Por RegiãoUSD
Nome
Receita
Proporção
United States
10.93M
83.85%
Europe,Middle East & Africa
1.37M
10.48%
Asia Pacific
671.00K
5.15%
Americas other
68.00K
0.52%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Device sales revenue
8.28M
63.54%
Consumables and service revenue
4.73M
36.31%
License and contract revenue
20.00K
0.15%
Distribuição de ações
Atualizado em: dom, 17 de ago
Atualizado em: dom, 17 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Outro
53.49%
Investidores
Investidores
Proporção
ARCH Venture Partners
15.87%
AWM Investment Company, Inc.
14.41%
State Street Investment Management (US)
6.34%
ARK Investment Management LLC
5.41%
BlackRock Institutional Trust Company, N.A.
4.48%
Outro
53.49%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
38.89%
Investment Advisor
22.60%
Venture Capital
15.88%
Individual Investor
8.36%
Hedge Fund
3.22%
Research Firm
2.16%
Pension Fund
0.17%
Bank and Trust
0.09%
Insurance Company
0.03%
Outro
8.60%
Participação acionária institucional
Atualizado em: dom, 5 de out
Atualizado em: dom, 5 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
223
29.97M
83.04%
-3.25M
2025Q2
226
29.86M
82.76%
-3.27M
2025Q1
235
29.47M
83.22%
+34.34K
2024Q4
242
25.43M
73.04%
-4.66M
2024Q3
246
27.53M
79.50%
-3.86M
2024Q2
248
28.48M
83.77%
-4.52M
2024Q1
241
29.63M
90.49%
-5.18M
2023Q4
255
31.02M
95.84%
-3.81M
2023Q3
261
30.10M
93.52%
-5.15M
2023Q2
268
30.29M
94.48%
-6.54M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
ARCH Venture Partners
5.73M
15.87%
--
--
Apr 17, 2025
AWM Investment Company, Inc.
5.20M
14.41%
--
--
Jun 30, 2025
State Street Investment Management (US)
2.29M
6.34%
+1.82M
+388.85%
Jun 30, 2025
ARK Investment Management LLC
2.65M
7.34%
-251.07K
-8.66%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.62M
4.48%
+115.41K
+7.69%
Jun 30, 2025
The Vanguard Group, Inc.
1.43M
3.97%
+68.94K
+5.06%
Jun 30, 2025
Knopp (Kevin J)
1.26M
3.5%
+30.00K
+2.43%
May 15, 2025
GM Advisory Group, LLC
1.17M
3.23%
+1.17M
--
Jun 30, 2025
First Light Asset Management, LLC
1.07M
2.96%
-633.48K
-37.24%
Jun 30, 2025
Brown (Christopher D)
962.12K
2.67%
--
--
Apr 17, 2025
Ver Mais
ETFs Relacionados
Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
ARK Genomic Revolution ETF
1.49%
SPDR S&P Kensho Future Security ETF
1.32%
SPDR S&P Kensho New Economies Composite ETF
0.57%
iShares Micro-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Ver Mais
ARK Genomic Revolution ETF
Proporção1.49%
SPDR S&P Kensho Future Security ETF
Proporção1.32%
SPDR S&P Kensho New Economies Composite ETF
Proporção0.57%
iShares Micro-Cap ETF
Proporção0.05%
Avantis US Small Cap Equity ETF
Proporção0.03%
iShares Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
iShares Russell 2000 Growth ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
